Product Description
| Cat Number | GE-010 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | GPER inverse agonist |
| Modification | None |
| Purity | >95% by hplc |
| Biomarker Target | G protein-coupled estrogen receptors |
| Sequence Three Letter Code | H-Pro-Leu-Met-Ile-Lys-Arg-Ser-Lys-Lys-Asn-Ser-Leu-Ala-Leu-Ser-Leu-Thr-OH |
| Molecular Formula | C84H154N24O23S |
| Sl Sequence | PLMIKRSKKNSLALSLT |
| Solubility | Soluble in water |
| Appearance | Freeze dried solid |
| Storage | Store dry, frozen and in the dark |
| References |
Mallet et al (2021) The Antitumor Peptide ERα17p Exerts Anti-Hyperalgesic and Anti-Inflammatory Actions Through GPER in Mice. Front Endocrinol. 12 578250 PMID: 33815268Jouffre et al (2023) Identification of a human estrogen receptor α tetrapeptidic fragment with dual antiproliferative and anti-nociceptive action. Sci Rep. 13(1) 1326 PMID: 36693877Kampa et al (2023) Promising Perspectives of the Antiproliferative GPER Inverse Agonist ERα17p in Breast Cancer. Cells 12(4) 653 PMID: 36831322 Related areas All peptides >All G protein-coupled estrogen receptor modulators >All cancer research categories > |
| Note | The product is for research use only |
Share Item: